| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e74277852f1aae0a3ff13f59a65456d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9172855712d867da49fe80ebc339026a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-166 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
| filingDate |
2018-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0482ddf194f7da56738be5ccc825350d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bafe4f7a49cc5298e5b049d84ef0d40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26fbeb52d872b4eb00be9254cb44281c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48567cc0d062782e582d49297b7b4eba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64a0b2b88f183c89e3484d055941e352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bc99b599860584934a8a2d391128a46 |
| publicationDate |
2020-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111286531-A |
| titleOfInvention |
Application of Circulating Nucleic Acids as Markers of Hypertension, Diabetes and Hyperlipidemia |
| abstract |
The present invention relates to the use of circulating nucleic acids as markers of hypertension, diabetes and hyperlipidemia. The present invention identifies a group of miRNA marker molecules for atherosclerosis-related diseases through specific systematic screening of serum circulating miRNAs of patients with coronary heart disease and establishment of a stable detection method; the present invention further conducts case-control studies and prospective population The study found an important contribution of circulating miRNAs in the prediction of atherosclerosis-related diseases. The results of this study will provide an important theoretical and methodological basis for the clinical application of circulating miRNAs. |
| priorityDate |
2018-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |